SELLAS Life Sciences (SLS) Inventory (2013 - 2015)

SELLAS Life Sciences' (SLS) quarterly Inventory came in at $1.4 million in Q2 2015, up 229.33% year-on-year from $433000.0 in Q2 2014, and up 123.86% on a QoQ basis from $637000.0 in Q1 2015.

SELLAS Life Sciences (SLS) Inventory (2013 - 2015) Analysis & Trends

SELLAS Life Sciences (SLS) has 3 years of Inventory data on file, last reported at $1.4 million in Q2 2015.

  • On a quarterly basis, Inventory rose 229.33% year-over-year to $1.4 million in Q2 2015; TTM through Jun 2015 was $1.4 million, a 229.33% increase from a year earlier, with the FY2014 full-year figure at $655000.0, up 69.69% from the prior year.
  • Inventory for Q2 2015 stood at $1.4 million, up from $637000.0 in the prior quarter.
  • Over the last five years, Inventory for SLS reached as high as $1.4 million in Q2 2015 and fell as low as $352000.0 in Q2 2013.
  • Historically, Inventory has averaged $569111.1 across 3 years, with a median of $433000.0 in 2014.
  • Across the five-year window, Inventory rose 5.88% in 2014 and surged 229.33% in 2015, its largest moves.
  • Year by year, Inventory stood at $386000.0 in 2013, then jumped by 69.69% to $655000.0 in 2014, then jumped by 117.71% to $1.4 million in 2015.
  • Per Business Quant data, the three most recent Inventory figures were $1.4 million in Q2 2015, $637000.0 in Q1 2015, and $655000.0 in Q4 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 681.59 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.77 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 3.10 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 371.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 SELLAS Life Sciences 3.23 Mn 3.23 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2015 1.43 Mn
Mar 31, 2015 637,000.00
Dec 31, 2014 655,000.00
Sep 30, 2014 450,000.00
Jun 30, 2014 433,000.00
Mar 31, 2014 358,000.00
Dec 31, 2013 386,000.00
Sep 30, 2013 425,000.00
Jun 30, 2013 352,000.00